SGT Incorporated, NASA Ames Research Center, Mountain View, California, United States.
NASA Johnson Space Center, Houston, Texas, United States.
Invest Ophthalmol Vis Sci. 2020 Dec 1;61(14):34. doi: 10.1167/iovs.61.14.34.
Ocular structural and functional changes, collectively termed spaceflight-associated neuro-ocular syndrome (SANS), have been described in astronauts undergoing long-duration missions in the microgravity environment of the International Space Station. We tested the hypothesis that retinal vascular remodeling, particularly by smaller vessels, mediates the chronic headward fluid shifts associated with SANS.
As a retrospective study, arterial and venous patterns extracted from 30° infrared Heidelberg Spectralis retinal images of eight crew members acquired before and after six-month missions were analyzed with NASA's recently released VESsel GENeration Analysis (VESGEN) software. Output parameters included the fractal dimension and overall vessel length density that was further classified into large and small vascular branching generations. Vascular results were compared with SANS-associated clinical ocular measures.
Significant postflight decreases in Df, Lv, and in smaller but not larger vessels were quantified in 11 of 16 retinas for arteries and veins (P value for Df, Lv, and smaller vessels in all 16 retinas were ≤0.033). The greatest vascular decreases occurred in the only retina displaying clinical evidence of SANS by choroidal folds and optic disc edema. In the remaining 15 retinas, decreases in vascular density from Df and Lv ranged from minimal to high by a custom Subclinical Vascular Pathology Index.
Together with VESGEN, the Subclinical Vascular Pathology Index may represent a new, useful SANS biomarker for advancing the understanding of SANS etiology and developing successful countermeasures for long duration space exploration in microgravity, although further research is required to better characterize retinal microvascular adaptations.
在国际空间站微重力环境下进行长期任务的宇航员中,已描述了与空间相关的神经眼综合征(SANS)的眼部结构和功能变化。我们检验了这样一个假设,即视网膜血管重塑,特别是通过较小的血管,介导了与 SANS 相关的慢性头部流体移位。
作为一项回顾性研究,对 8 名机组人员在进行为期 6 个月的任务前后获得的 30°红外海德堡 Spectralis 视网膜图像的动脉和静脉模式进行了分析,使用的是 NASA 最近发布的 VESsel GENeration Analysis(VESGEN)软件。输出参数包括分形维数和总体血管长度密度,后者进一步分为大血管和小血管分支世代。将血管结果与 SANS 相关的临床眼部测量值进行了比较。
在 16 个视网膜中的 11 个中量化了 Df、Lv 和较小但不是较大血管的显著飞行后下降(在所有 16 个视网膜中 Df、Lv 和较小血管的 P 值均≤0.033)。在唯一显示脉络膜褶皱和视盘水肿临床 SANS 证据的视网膜中,血管减少最大。在其余 15 个视网膜中,Df 和 Lv 的血管密度下降范围从最小到高,采用自定义亚临床血管病理学指数。
与 VESGEN 一起,亚临床血管病理学指数可能代表了一种新的、有用的 SANS 生物标志物,可用于深入了解 SANS 的病因,并为在微重力下进行长期太空探索开发成功的对策,尽管需要进一步研究以更好地描述视网膜微血管适应性。